Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

GAM product evaluated in phase I trial for diabetic foot ulcers

Nov. 29, 2002

PCL-016 enters phase IIa in acne

Nov. 28, 2002

SRP-299 enters phase II in childhood atopic dermatitis

Nov. 27, 2002

RegeneRx files IND for thymosin beta 4

Nov. 20, 2002

U. of British Columbia and ARC sign license agreement for novel antiinflammatories

Nov. 19, 2002

Recombinant alpha 1-antitrypsin topical gel enters clinical trials

Nov. 14, 2002

Update of PVAC treatment program for psoriasis

Nov. 13, 2002

Enrollment begins in pivotal phase III trials of Atrisone for acne

Nov. 8, 2002

Approvable letter for Olux expanded label

Oct. 31, 2002

Second Allox phase I/II trial completed

Oct. 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...